WEC
BDSX icon

Winslow Evans & Crocker’s Biodesix BDSX Stock Holding History

Winslow Evans & Crocker’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1K Buy
+3
New +$934 ﹤0.01% 1264

Other funds holding BDSX

BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
ACM
Asymmetry Capital Management San Francisco, California $188M AUM 44.72% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Winslow Evans & Crocker's BDSX Position: Q4 2020 in Review

Winslow Evans & Crocker opened a new position in Biodesix (BDSX) in Q4 2020: 3 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1264 among its holdings.

47 funds tracked by Wall St. Rank hold BDSX as of Q4 2020.

  • Winslow Evans & Crocker held 3 shares of Biodesix worth $1K as of Q4 2020.
  • Biodesix was a new Winslow Evans & Crocker position in Q4 2020.
  • Biodesix made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #1264 holding.
  • 47 funds tracked by Wall St. Rank held Biodesix as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.